Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Indo Straits Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp254 (kapitalisasi pasar 172,82 M, volume 24 jam 592,2 rb), sedangkan Indo Straits Tbk. diperdagangkan di Rp270 (kapitalisasi pasar 149,64 M, volume 24 jam 147,4 rb). Perbedaan utamanya: Brigit Biofarmaka Teknologi Tbk. lebih besar dari sisi kapitalisasi pasar, dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (592,2 rb vs 147,4 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | PTIS | |
|---|---|---|
Kapitalisasi Pasar | 172,82 M | 149,64 M |
Volume | 592,2 rb | 147,4 rb |
Lot | 5,92 rb | 1,47 rb |
Perputaran | 147,05 jt | 39,56 jt |
Harga Rata-rata | 248,31 | 268,4 |
Nilai Transaksi | 147,05 jt | 39,56 jt |
Harga Ekuilibrium Indikatif | 254 | 270 |
Volume Ekuilibrium Indikatif | 10 | 71 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT Indo Straits (the "Company") was established based on Notarial Deed No 319 of Ridwan SH, dated January 21, 1985. The Company's Articles of Association have been amended several times. The latest amendment was based on Notarial Deed No. 4 of Leolin Jayanti SH dated March 8, 2011 pertaining of change composition of the Company's board of Commissioners and Boards of Directors, issuance of new share to be offered to the public in the Initial Public Offering, and amendment of the Article of Association of the Company to become a public entity.
Selengkapnya di halaman PTIS →